세계의 허혈성 뇌졸중 수술 시장 : 수술 유형별, 제품 유형별, 최종사용자별, 지역별(-2035년)

Global Ischemic Stroke Surgery Market Research Report by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, Others), by Product Type (Catheters, Aspiration System, Guidewire, Microcatheter, Others), by End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and by Region (North America, Europe, Asia Pacific, Rest of the World) Industry Forecast till 2035

Industry Overview

The global ischemic stroke surgery market reached USD 2,291.16 million in 2021 and is projected to achieve USD 7,266.15 million with a CAGR of 8.70% by the end of 2035. Ischemic stroke surgery is a medical procedure used to remove blood clots and restore blood flow to the brain. It helps reduce brain damage and improves recovery chances in patients suffering from acute ischemic stroke.

An increase in physical inactivity and poor lifestyle choices is pushing the demand in the global ischemic stroke surgery market. Advanced surgical methods and tools are making treatments more effective. Patients are also choosing less invasive procedures for quicker recovery.

The presence of limited medical infrastructure and a lack of experienced professionals is slowing the progress of the global ischemic stroke surgery industry. Still, with more research and investment, the ischemic stroke surgery market is finding new paths for development.

Industry Segmentations

In terms of product type, the global market is divided into catheters, aspiration systems, guidewires, microcatheters, and others.

Based on the type of surgery, the global ischemic stroke surgery market is classified into Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, and others.

The global ischemic stroke surgery market is segmented based on the end-users, including hospitals and clinics, ambulatory surgical centers, and others.

Regional Analysis

The ischemic stroke surgery market is still expanding rapidly in North America due to a large number of stroke cases and rising utilization of cutting-edge techniques like endovascular thrombectomy. An increasing senior population, more awareness, and technological advancements are all driving market expansion.

New research and successful treatments like thrombectomy are driving the growth of the ischemic stroke surgery market in Europe. The region's stroke treatment results are improving because of strong support for healthcare innovation.

The ischemic stroke surgery market is broadening quickly in the Asia-Pacific as governments increase their spending on research and healthcare. New treatments are becoming more widely available in nations like South Korea, Japan, and India, which is helping patients recover.

Latin America, the Middle East, and Africa are experiencing a rise in stroke-related illnesses, creating a higher demand for surgery. Better medical infrastructure and health programs are helping these regions grow in the global market.

Key Players

Major players in the global ischemic stroke surgery market are Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Cordis Corporation, Johnson & Johnson Services Inc., Koninklijke Philips N.V., Stryker, Imperative Care, Penumbra, Inc., and Phenox GmbH.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE
• 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

• 3.1 DATA MINING
• 3.2 SECONDARY RESEARCH
• 3.3 PRIMARY RESEARCH
• 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 RISE IN PHYSICAL INACTIVITY AND SEDENTARY LIFESTYLES
  • 4.2.2 ADOPTION AND LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS
  • 4.2.3 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
• 4.3 RESTRAINTS
  • 4.3.1 LACK OF MEDICAL FACILITIES
  • 4.3.2 SHORTAGE OF SKILLED PROFESSIONALS
• 4.4 OPPORTUNITIES
  • 4.4.1 R&D ACTIVITIES AND INVESTMENTS

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D
  • 5.1.2 MANUFACTURING
  • 5.1.3 DISTRIBUTION AND SALES
  • 5.1.4 POST-SALES MONITORING
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • 5.3.1 IMPACT ON SUPPLY CHAIN
  • 5.3.2 IMPACT ON PRODUCTION
  • 5.3.3 IMPACT ON DEMAND
• 5.4 EPIDEMIOLOGY ANALYSIS
  • 5.4.1 INCIDENCE & PREVALENCE
  • 5.4.2 NUMBER OF PROCEDURES FOR THROMBECTOMY
• 5.5 REGULATORY ANALYSIS/HEALTHCARE SYSTEM

6 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY

• 6.1 OVERVIEW
• 6.2 THROMBECTOMY
• 6.3 REVASCULARIZATION SURGERY
• 6.4 CAROTID ENDARTERECTOMY
• 6.5 ANGIOPLASTY
• 6.6 OTHERS

7 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE

• 7.1 OVERVIEW
• 7.2 CATHETER
• 7.3 ASPIRATION SYSTEM
• 7.4 GUIDEWIRE
• 7.5 MICROCATHETER
• 7.6 OTHERS

8 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 HOSPITALS AND CLINICS
• 8.3 AMBUATORY SURGICAL CENTRES
• 8.4 OTHERS

9 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 UK
  • 9.3.3 FRANCE
  • 9.3.4 ITALY
  • 9.3.5 SPAIN
  • 9.3.6 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 JAPAN
  • 9.4.2 CHINA
  • 9.4.3 INDIA
  • 9.4.4 AUSTRALIA
  • 9.4.5 SOUTH KOREA
  • 9.4.6 REST OF ASIA PACIFIC
• 9.5 REST OF THE WORLD
  • 9.5.1 MIDDLE EAST
  • 9.5.2 AFRICA
  • 9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 MARKET SHARE ANAYISIS
• 10.3 COMPETITIVE BENCHMARKING
• 10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
• 10.5 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
• 10.6 KEY DEVELOPMENT ANALYSIS
• 10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.7.1 MERGER & ACQUISITIONS
  • 10.7.2 AGREEMENT/MARKETING STRATEGIES
• 10.8 FINANCIAL MATRIX
  • 10.8.1 SALES (USD MILLION), 2021
  • 10.8.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021

11 COMPANY PROFILES

• 11.1 MEDTRONIC PLC
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS/SERVICES OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES
• 11.2 ABBOTT LABORATORIES
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS/SERVICES OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 KEY STRATEGIES
• 11.3 BOSTON SCIENTIFIC CORPORATION
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCTS/SERVICES OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 KEY STRATEGIES
• 11.4 CORDIS CORPORATION
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS/SERVICES OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 KEY STRATEGIES
• 11.5 KONINKLIJKE PHILIPS N.V
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS/SERVICES OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 SWOT ANALYSIS
  • 11.5.6 KEY STRATEGIES
• 11.6 STRYKER
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 SWOT ANALYSIS

1 1.6.6 KEY STRATEGIES

• 11.7 IMPERATIVE CARE
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 KEY STRATEGIES
• 11.8 JOHNSON & JOHNSON SERVICES, INC.
  • 11.8.1 COMPANY OVERVIEWS
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 SWOT ANALYSIS
  • 11.8.6 KEY STRATEGIES
• 11.9 PENUMBRA, INC.
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 SWOT ANALYSIS
  • 11.9.6 KEY STRATEGIES
• 11.10 PHENOXYHENOX GMBH
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 KEY STRATEGIES

12 APPENDIX

• 12.1 REFERENCES
• 12.2 RELATED REPORTS